Pharmaceutical and Healthcare Industry in Argentina - Forecast and Analysis 2022

The COVID-19 pandemic brought about renewed investment in the Argentinian healthcare and pharmaceutical sectors and a growing trend for non-communicable diseases in the population. Nevertheless, despite the increased investment, the government continues to be faced with financial and political challenges, which the pandemic further intensified. 

Argentina was one of the region's worst affected in terms of COVID-19 infections, and the pandemic and ensuing lockdown have had a significant economic impact on the country. With the vaccination program going on, there have been some delays in getting most of the population vaccinated.

Argentina is one of the top ten attractive pharmaceutical and healthcare markets in Latin America, and there are many revenue-generating opportunities for drugmakers, which is why the country is seeing a steady stream of investment in recent years. However, issues with intellectual property rights continue to plague the industry.

In this industry scenario, the publisher presents an in-depth analysis of the Pharmaceutical and Healthcare Industry of Argentina in its research report Pharmaceutical and Healthcare Industry in Argentina - Forecast and Analysis 2022.

The report covers the following data:

• A brief overview of the pharmaceutical and healthcare industry in the Americas and a snapshot of the sector across some leading and underperforming markets of the region.
• An in-depth coverage of the pharmaceutical and healthcare industry in Argentina by sectors along with an analysis of how the COVID-19 pandemic is effecting the industry.
• We analyze the segments of prescription drugs, generic drugs, OTC medicines, and also analyze the landscape for medical research and clinical trials in Argentina.
• A SWOT analysis of the Argentinian pharmaceutical and healthcare industry. 
• We take an up-close view of the regulatory framework governing the Argentinian pharmaceutical and healthcare industry, and the challenges being faced in terms of intellectual property rights. 
• Competition in the industry, along with an in-depth analysis of the both the domestic and multinational players in the sector like Laboratorios Bagó, GlaxoSmithKline, Merck & Co. Inc. (MSD), Novartis, Pfizer, and Sanofi SA.

A detailed forecast of the Argentinian pharmaceutical and healthcare industry by segments completes this comprehensive analysis.